proprietary medicine


Also found in: Thesaurus, Medical, Legal, Encyclopedia.
Related to proprietary medicine: Conventional medicine
Translations

pro·pri·e·tar·y med·i·cine

n. medicamento de patente.
Mentioned in ?
References in periodicals archive ?
Designed for the cultural historian, the bottle collector, and those interested in pharmacopeia, this book is a guide to the identification and evaluation of embossed, patent, and proprietary medicine bottles produced in an era of American history when anything could legally be bottled and sold.
NeuroAid(TM) is currently marketed in Singapore as a Chinese proprietary medicine, and in other countries in the region as a dietary supplement.
A Phase I trial of EHC18, Enzo's proprietary medicine for treating C-associated chronic active hepatitis, met its endpoints and plans for further study are underway.
NYSE:ENZ), encouraged by results thus far of its Phase 2 study of EHT899, the Company's proprietary medicine for treating patients suffering from chronic active hepatitis associated with hepatitis B virus ("HBV"), said it is planning to launch a multi-centered, double blind, randomized study of the product.
NYSE: ENZ) today reported preliminary results of its Phase II clinical trial of EHT899, the Company's proprietary medicine for treating patients suffering from chronic active hepatitis associated with hepatitis B virus ("HBV").
In a randomized, double-blind, placebo-controlled study reported in The Journal of Family Practice, a proprietary medicine made from Pelargonium sidoides roots (available in the U.
The Hadassah Medical Center is also the site of the Phase II trial of EHT899, Enzo's proprietary medicine for patients with hepatitis B virus infection.
27 /PRNewswire/ -- A new study has found that UMCKA(R) COLDCARE(TM), a proprietary medicine made from Pelargonium sidoides roots and introduced to the U.
In previous studies, the Hadassah-Enzo team had shown that it is possible to augment an anti-HBV immune response by oral administration of EHT899, Enzo's proprietary medicine for HBV that is currently in a Phase II clinical trial.